Trademark applications and grants for Astrazeneca Uk L T D. Astrazeneca Uk L T D has 145 trademark applications. The latest application filed is for "a symbol or image mark"
Patent Application | Date |
---|---|
METHODS OF PURIFYING ADENOVIRUS 20220186194 - 17/547317 LINKE; THOMAS ;   et al. | 2022-06-16 |
METHODS OF PRODUCING ADENOVIRUS 20220184156 - 17/547323 JIANG; JINLIN ;   et al. | 2022-06-16 |
SARS-COV-2 ANTIBODIES FOR TREATMENT AND PREVENTION OF COVID-19 20220041694 - 17/397203 GASSER; Robert ;   et al. | 2022-02-10 |
SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE SAME 20210355196 - 17/322137 ESSER; Mark ;   et al. | 2021-11-18 |
METHODS FOR TREATMENT OF HYPERTENSION WITH AN ANGIOTENSIN II RECEPTOR BLOCKER PHARMACEUTICAL COMPOSITION 20210327597 - 17/362654 SKELLY; Richard L. ;   et al. | 2021-10-21 |
NCAGE Code | K5485 | ASTRAZENECA UK LTD |
NCAGE Code | K4220 | ASTRAZENECA UK LTD |
CAGE Code | K4220 | ASTRAZENECA UK LTD |
CAGE Code | K5485 | ASTRAZENECA UK LTD |
SEC | 0001362825 | AstraZeneca UK LTD of UNITED KINGDOM |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.